Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group.

Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.

PMID:
20952254
2.

Global Variation of Human Papillomavirus Genotypes and Selected Genes Involved in Cervical Malignancies.

Husain RS, Ramakrishnan V.

Ann Glob Health. 2015 Sep-Oct;81(5):675-83. doi: 10.1016/j.aogh.2015.08.026. Review.

3.

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.

Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1157-64. Review.

4.

Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.

Ogembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, Ogembo JG.

PLoS One. 2015 Apr 14;10(4):e0122488. doi: 10.1371/journal.pone.0122488. eCollection 2015. Review.

5.

Cervical adenocarcinoma: moving towards better prevention.

Seoud M, Tjalma WA, Ronsse V.

Vaccine. 2011 Nov 15;29(49):9148-58. doi: 10.1016/j.vaccine.2011.09.115. Epub 2011 Oct 6. Review.

PMID:
21983356
6.

[Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].

Giorgi Rossi P, Chini F, Borgia P, Guasticchi G, Carozzi FM, Confortini M, Angeloni C, Buzzoni C, Buonaguro FM; Gruppo di lavoro HPV Prevalenza.

Epidemiol Prev. 2012 Mar-Apr;36(2):108-19. Review. Italian.

PMID:
22706361
7.

Human papillomavirus testing in the prevention of cervical cancer.

Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE.

J Natl Cancer Inst. 2011 Mar 2;103(5):368-83. doi: 10.1093/jnci/djq562. Epub 2011 Jan 31. Review.

8.

Detection of human papillomavirus in esophageal and gastroesophageal junction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience from Turkey and review of literature.

Türkay DÖ, Vural Ç, Sayan M, Gürbüz Y.

Pathol Res Pract. 2016 Feb;212(2):77-82. doi: 10.1016/j.prp.2015.10.007. Epub 2015 Oct 23. Review.

PMID:
26608416
9.

Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.

Richart RM, Masood S, Syrjänen KJ, Vassilakos P, Kaufman RH, Meisels A, Olszewski WT, Sakamoto A, Stoler MH, Vooijs GP, Wilbur DC.

Acta Cytol. 1998 Jan-Feb;42(1):50-8. Review.

PMID:
9479323
10.

A Contemporary Review of HPV and Penile Cancer.

Stratton KL, Culkin DJ.

Oncology (Williston Park). 2016 Mar;30(3):245-9. Review.

11.

Clinical significance of human papillomavirus genotyping.

Choi YJ, Park JS.

J Gynecol Oncol. 2016 Mar;27(2):e21. doi: 10.3802/jgo.2016.27.e21. Review.

12.

Advances in cervical cancer screening and human papillomavirus vaccines.

Feeley C.

J Br Menopause Soc. 2006 Mar;12(1):19-23. Review.

PMID:
16513018
13.

Human papillomavirus and cervical cancer.

Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S.

Lancet. 2007 Sep 8;370(9590):890-907. Review.

PMID:
17826171
14.
15.

Human papilloma virus (HPV) molecular diagnostics.

Kroupis C, Vourlidis N.

Clin Chem Lab Med. 2011 Nov;49(11):1783-99. doi: 10.1515/CCLM.2011.685. Epub 2011 Aug 30. Review.

PMID:
21875401
16.

Cervical cancer prevention: immunization and screening 2015.

Thaxton L, Waxman AG.

Med Clin North Am. 2015 May;99(3):469-77. doi: 10.1016/j.mcna.2015.01.003. Epub 2015 Feb 28. Review.

PMID:
25841595
17.

The known unknowns of HPV natural history.

Gravitt PE.

J Clin Invest. 2011 Dec;121(12):4593-9. doi: 10.1172/JCI57149. Epub 2011 Dec 1. Review.

18.

New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention.

Gersch ED, Gissmann L, Garcea RL.

Antivir Ther. 2012;17(3):425-34. doi: 10.3851/IMP1941. Epub 2011 Nov 7. Review.

19.
20.

Are 20 human papillomavirus types causing cervical cancer?

Arbyn M, Tommasino M, Depuydt C, Dillner J.

J Pathol. 2014 Dec;234(4):431-5. doi: 10.1002/path.4424. Review.

PMID:
25124771

Supplemental Content

Support Center